Chris LeBlanc is a highly experienced Business Manager in the areas of: Strategic Planning, Marketing, Sales, Key Account Management and Finance.

Chris started his career at 3M in 2005 as Marketing Manager for Food & Beverage Market Centre. From there, he held various Sales and Marketing roles in 3M’s Industrial Business Group, and in 2010 he assumed the responsibility of Corporate Marketing & Strategy Manager for 3M Australia and New Zealand.

Chris progressed his career leading as General Manager of Consumer Business from 2014 to 2017, Safety & Graphics Business from 2017 to 2018, then Safety & Industrial, Transportation & Electronics Business from early 2019.

In January 2020, Chris was appointed in the dual role of ANZ Managing Director, and General Manager of the combined areas of Safety & Industrial Business for Australia and New Zealand – one of the largest businesses for 3M in the Region.

Chris’ professional education includes a Master’s Degree in Business Marketing, Bachelor’s Degree in Business Management Administration, and Diplomas in Graphic Design, Interactive Marketing and Business Management.

Having joined Stuart Alexander & Co as General Manager, Sales and Marketing in early 2017, Nick was appointed to CEO in January 2018.

Nick has a strong background in FMCG having held several senior roles across organisations such as DBG Australia part of Heineken, Frucor Beverages and PepsiCo.

Kathy is the Senior Director of New Ventures, Australia and New Zealand (ANZ) for Johnson & Johnson Innovation, West North America, Australia & New Zealand and is responsible for implementing the Johnson & Johnson external partnerships and growth strategy across ANZ. As the technology scout for the pharmaceutical, medical device and consumer health businesses, Kathy is passionate about encouraging and building global collaborations to deliver new and disruptive healthcare solutions for people everywhere. In 2016 Kathy pioneered the Australian Johnson & Johnson Innovation Partnering Office (JJIPO) model – a public private partnership model involving Johnson & Johnson, host universities and State governments to help connect, train and invest in local innovation ecosystems.

Prior to joining Johnson & Johnson Innovation, Kathy was the head of Innovation and Investment for Janssen ANZ, held business development roles at Sanofi to drive in-licensing, out-licensing and acquisition activities for the ANZ and Asia Pacific businesses across the pharmaceutical and consumer health sectors and was the Global VP of Business Development for an Australian biotech company. Kathy is the co-founder of PAIG (Pharmaceutical Australia Inclusion Group) and is a recognised leader and advocate for diversity and inclusion in the life sciences sector. Kathy has a clinical, commercial and legal background with more than 25 years cross-sector experience including in the pharmaceutical, biotechnology, academia and hospital industries. She is based in Sydney Australia.

Michael Cossetto is the Head of the Corporate & Commercial Group at Bartier Perry. He has 25 years’ experience acting for businesses, not-for-profits and government bodies across a range of legal transactions. He has a special interest in licensing and distribution, as well as a deep understanding of intellectual property law. He regularly advises clients about supply chain issues, with a focus on the FMCG sector. Over the last few months he has been assisting clients navigate through various COVID-19 related supply chain issues, such as force majeure, contract frustration, exclusivity, minimum order and price adjustments, which often become even more complicated when dealing with international suppliers or customer. He is on the board of the Licensing Executive Society of Australia and New Zealand, and a member of the AMCHAM FMCG Special Interest Group.